Every 8-K that Iveda Solutions, Inc. (IVDA) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow IVDA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IVDA filings page.
Iveda Solutions, Inc. (IVDA) reports that Nasdaq has granted an additional 180‑day grace period, through March 1, 2027, to regain compliance with the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2). The extension follows Iveda meeting all other applicable initial listing standards, including the market value of publicly held shares.
To regain compliance, Iveda’s common stock must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during this new period, with Nasdaq able to require a longer span. Iveda states it will monitor its share price and other listing standards and may consider a reverse stock split if appropriate, but has not decided to implement one. The company cautions there is no assurance it will regain or maintain compliance; failure to do so by March 1, 2027 could result in delisting, subject to any appeal.
Iveda Solutions, Inc. has been notified by Nasdaq that its common stock no longer meets the exchange’s minimum bid price requirement of $1 per share, after trading below that level for 30 consecutive business days. The notice does not immediately affect the stock’s Nasdaq listing.
The company has 180 calendar days, until September 2, 2026, to regain compliance. Nasdaq will deem the requirement met if the closing bid price is at least $1 for a minimum of ten consecutive business days during this period. If compliance is not restored or other listing rules are breached, Nasdaq may move to delist the shares, although Iveda could appeal any delisting determination to a Nasdaq Hearings Panel.
Iveda Solutions, Inc. completed a public offering of 5,714,286 shares of common stock (or pre-funded warrants in lieu) and Series X warrants to purchase up to 11,428,572 shares at a combined price of $0.35. The transaction generated approximately $2 million in gross proceeds before fees and expenses. The company issued additional placement agent warrants and paid cash fees to H.C. Wainwright & Co. and plans to use the net proceeds for general corporate purposes, including potential R&D, debt repayment, working capital, capital spending, acquisitions, joint ventures, and stock repurchase programs. The offering was conducted under an effective Form S-1 registration statement.
Iveda Solutions, Inc. (IVDA) has resolved a prior Nasdaq listing deficiency. On May 27, 2025, the company was notified that it did not meet Nasdaq Capital Market standards requiring at least $2,500,000 in stockholders’ equity, or a $35 million market value of listed securities, or $500,000 of net income from continuing operations for continued listing. Based on its Form 10-Q for the quarter ended September 30, 2025, Iveda reported $3,768,242 of stockholders’ equity. Nasdaq staff advised on November 25, 2025 that the company now complies with these rules and the listing matter is closed.